Flexeril /00428402/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 69.2%
Drug Abuse 15.4%
Pain 5.1%
Substance Abuse 5.1%
Arthralgia 2.6%
Back Pain 2.6%
Substance Abuse 37.5%
Hypersomnia 12.5%
Oedema 12.5%
Overdose 12.5%
Sepsis 12.5%
Suicidal Ideation 12.5%
Concomitant
Product Used For Unknown Indication 65.3%
Pain 6.3%
Rheumatoid Arthritis 5.2%
Hepatitis C 2.9%
Muscle Spasms 2.9%
Back Pain 2.2%
Supplementation Therapy 1.7%
Depression 1.6%
Migraine 1.5%
Fibromyalgia 1.4%
Hypertension 1.2%
Psoriatic Arthropathy 1.2%
Insomnia 1.1%
Plasma Cell Myeloma 1.1%
Nausea 0.9%
Multiple Sclerosis 0.8%
Anxiety 0.7%
Psoriasis 0.7%
Blood Cholesterol 0.6%
Cough 0.6%
Injection Site Pain 11.7%
Drug Ineffective 9.4%
Sinusitis 7.8%
Therapeutic Response Decreased 7.8%
Pain 7.0%
Vomiting 6.3%
Nausea 5.5%
Urinary Tract Infection 5.5%
Urticaria 4.7%
Rash 3.9%
Weight Increased 3.9%
Injection Site Swelling 3.1%
Musculoskeletal Pain 3.1%
Nasopharyngitis 3.1%
Paraesthesia 3.1%
Rheumatoid Arthritis 3.1%
Upper Respiratory Tract Infection 3.1%
White Blood Cell Count Increased 3.1%
Injection Site Bruising 2.3%
Injection Site Erythema 2.3%

Drug Data